Skip to main content

Find Clinical Trials

Home
Conditions
RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy

Clinical trial condition

RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy

Explore clinical trials studying RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy trial results

Completed

Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL)

NCT04611880

Conditions: RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy, Vasculopathy, Retinal, With Cerebral Leukodystrophy
Locations: Andria Ford St Louis, Missouri, United States

Perelman School of Medicine; University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Vasculopathy, Retinal, With Cerebral Leukodystrophy (1)